1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
  5. > Interventional Cardiology & Peripheral Vascular Devices Market - Forecasts to 2019

The interventional cardiology and peripheral vascular devices market is expected to reach $26.72 billion by 2019 from $18.73 billion in 2014, at a CAGR of 7.4%. The global interventional cardiology and peripheral vascular devices market is segmented based on products and geography. Based on products, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories.

The angioplasty stents segment accounted for the largest share of the interventional cardiology and peripheral vascular devices market during the forecast period. The large share of this segment is attributed to the rising prevalence of cardiovascular diseases and increasing initiatives by companies for developing new and technologically advanced stents for better clinical outcomes.

Major factors contributing to the growth of the interventional cardiology and peripheral vascular devices market include rising aging population, increasing demand of minimally invasive procedures, rising incidence of cardiovascular diseases, and technological advancements. According to the World Health Organization, in 2012, 17.5 million people died due to CVDs; this figure accounted for 31% of the global deaths in 2012. Furthermore, in the same year, 16 million people aged below 70 years died due to non-communicable diseases; of this, 37% deaths were related to CVDs. Emerging markets in Asia have opened an array of opportunities for the growth of the interventional cardiology and peripheral vascular devices market. However, product failures and barriers to entry for small players are expected to restrain the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on product portfolios of the top players in the interventional cardiology and peripheral vascular devices market. The report analyzes the interventional cardiology and peripheral vascular devices market by product and geography
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the interventional cardiology and peripheral vascular devices market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional cardiology and peripheral vascular devices market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various devices across geographies
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the interventional cardiology and peripheral vascular devices market

Table Of Contents

Interventional Cardiology and Peripheral Vascular Devices Market - Forecasts to 2019
TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 MARKET SCOPE 23
1.3.1 MARKET SEGMENTATION 23
1.3.2 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY 24
1.5 LIMITATION 24
1.6 MARKET STAKEHOLDERS 24
2 RESEARCH METHODOLOGY 25
2.1 MARKET SIZE ESTIMATION 26
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.3 MARKET SHARE ESTIMATION 30
2.4 KEY DATA FROM SECONDARY SOURCES 30
2.5 KEY DATA FROM PRIMARY SOURCES 31
2.6 KEY INDUSTRY INSIGHTS 32
2.7 ASSUMPTIONS FOR THE STUDY 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 37
4.1 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES: MARKET OPPORTUNITIES 37
4.2 ANGIOPLASTY STENTS MARKET, BY TYPE 38
4.3 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,
BY REGION 39
4.4 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE 40
4.5 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE 41
4.6 CATHETERS MARKET, BY TYPE 42
4.7 LIFECYCLE ANALYSIS, BY REGION 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 45
5.2 MARKET SEGMENTATION 45
5.2.1 ANGIOPLASTY BALLOONS MARKET, BY TYPE 45
5.2.2 ANGIOPLASTY STENTS MARKET, BY TYPE 45
5.2.3 CATHETERS MARKET, BY TYPE 46
5.2.4 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET, BY TYPE 46
5.2.5 INFERIOR VENA CAVA FILTERS (IVC) MARKET, BY TYPE 46
5.2.6 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE 47
5.2.7 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE 47
5.2.8 ACCESSORY DEVICES MARKET, BY TYPE 47
5.2.9 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION 48
5.3 MARKET DYNAMICS 48
5.3.1 DRIVERS 50
5.3.1.1 Growth in aging population 50
5.3.1.2 Increasing demand for minimally invasive angioplasty procedures 50
5.3.1.3 Technological advancements in interventional cardiology and peripheral vascular devices 51
5.3.2 RESTRAINTS 52
5.3.2.1 Availability of effective conventional first-level medication 52
5.3.2.2 Product failure and product recall 52
5.3.3 OPPORTUNITIES 53
5.3.3.1 Bioabsorbable stents 53
5.3.3.2 Emerging markets 53
5.3.4 CHALLENGES 54
5.3.4.1 Varying reimbursements 54
5.3.4.2 Entry barriers for new players 54
6 INDUSTRY INSIGHTS 55
6.1 PORTER'S FIVE FORCES ANALYSIS 55
6.1.1 THREAT OF NEW ENTRANTS 55
6.1.2 BARGAINING POWER OF SUPPLIERS 56
6.1.3 BARGAINING POWER OF BUYERS 56
6.1.4 INTENSITY OF COMPETITIVE RIVALRY 56
6.1.5 THREAT OF SUBSTITUTES 56
6.2 SUPPLY CHAIN ANALYSIS 57
6.3 APPROVED INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES PRODUCTS 58
7 ANGIOPLASTY MARKET SIZE, BY TYPE OF PROCEDURE 60
7.2 INTRODUCTION 61
7.3 PLAIN OLD BALLOON ANGIOPLASTY (POBA) 62
7.4 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) 62
7.5 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) 63

8 ANGIOPLASTY BALLOONS MARKET, BY TYPE 64
8.1 INTRODUCTION 65
8.2 ANGIOPLASTY BALLOONS MARKET, BY TYPE 67
8.2.1 OLD/NORMAL BALLOONS 67
8.2.2 CUTTING AND SCORING BALLOONS 68
8.2.3 DRUG-ELUTING BALLOONS 69
8.3 ANGIOPLASTY BALLOON MATERIAL 71
8.3.1 NON-COMPLIANT BALLOONS 71
8.3.2 SEMI-COMPLIANT BALLOONS 71
8.3.3 LOW-COMPLIANT BALLOONS 71
8.4 ANGIOPLASTY BALLOON PLATFORMS 72
8.4.1 OVER-THE-WIRE (OTW) BALLOON CATHETERS 72
8.4.2 RAPID-EXCHANGE (RX) BALLOON CATHETERS 72
8.4.3 FIXED-WIRE BALLOON CATHETERS 72
9 ANGIOPLASTY STENTS MARKET, BY TYPE 73
9.1 INTRODUCTION 74
9.2 ANGIOPLASTY STENTS, BY TYPE 76
9.2.1 BARE-METAL STENTS 76
9.2.2 DRUG-ELUTING STENTS 77
9.2.3 BIOABSORBABLE STENTS 78
9.3 ANGIOPLASTY STENTS, BY DELIVERY PLATFORM 80
9.3.1 SELF-EXPANDING STENTS 80
9.3.2 BALLOON-EXPANDABLE STENTS 80
10 CATHETERS MARKET, BY TYPE 81
10.1 INTRODUCTION 82
10.2 GUIDING CATHETERS 84
10.3 ANGIOGRAPHY CATHETERS 85
10.4 INTRAVASCULAR ULTRASOUND (IVUS) CATHETERS/OPTICAL COHERENCE TOMOGRAPHY (OCT) CATHETERS 87
11 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET,
BY TYPE 90
11.1 INTRODUCTION 91
11.2 ABDOMINAL AORTIC ANEURYSMS 93
11.3 THORACIC AORTIC ANEURYSMS 95
12 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE 98
12.1 INTRODUCTION 99
12.2 PERMANENT FILTERS 102
12.3 RETRIEVABLE FILTERS 103
13 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE 105
13.1 INTRODUCTION 106
13.2 THROMBECTOMY DEVICES 108
13.3 ATHERECTOMY DEVICES 109
14 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE 111
14.1 INTRODUCTION 112
14.2 EMBOLIC PROTECTION DEVICES 114
14.3 CHRONIC TOTAL OCCLUSION DEVICES 115
15 ACCESSORIES MARKET, BY TYPE 117
15.1 INTRODUCTION 118
15.2 VASCULAR CLOSURE DEVICES (VCDS) 120
15.3 INTRODUCER SHEATHS 122
15.4 GUIDE WIRES 124
15.5 BALLOON INFLATION DEVICES 125
16 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION 127
16.1 INTRODUCTION 128
16.2 NORTH AMERICA 130
16.2.1 U.S. 135
16.2.2 CANADA 139
16.3 EUROPE 144
16.4 ASIA 149
16.5 ROW 154
17 COMPETITIVE LANDSCAPE 158
17.1 OVERVIEW 158
17.2 MARKET SHARE ANALYSIS 159
17.3 COMPETITIVE SITUATION AND TRENDS 160
17.3.1 REGULATORY APPROVALS 161
17.3.2 NEW PRODUCT LAUNCHES 162
17.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 163
17.3.4 ACQUISITIONS 164
17.3.5 OTHER DEVELOPMENTS 165

18 COMPANY PROFILES 166
(Overview, Financials, Products and Services, Strategy, and Developments)*
18.1 INTRODUCTION 166
18.2 ABBOTT LABORATORIES 167
18.3 ACCESSCLOSURE INC. 170
18.4 ALN IMPLANTS CHIRURGICAUX 172
18.5 APTUS ENDOSYSTEMS INC. 173
18.6 ASAHI INTECC CO. LTD 174
18.7 B. BRAUN MELSUNGEN AG 176
18.8 BIOSENSORS INTERNATIONAL GROUP LTD 179
18.9 BIOTRONIK SE and CO. KG 181
18.10 BOLTON MEDICAL, INC. 183
18.11 BOSTON SCIENTIFIC CORPORATION 184
18.12 C.R. BARD 188
18.13 COOK MEDICAL. INC. 190
18.14 CORDIS CORPORATION (A SUBSIDIARY OF JOHNSON and JOHNSON CO.) 191
18.15 EDWARDS LIFESCIENCES CORPORATION 193
18.16 EMBOLINE, INC. 195
18.17 ENDOLOGIX, INC. 196
18.18 INSITU TECHNOLOGIES, INC. 198
18.19 JOTEC GMBH 199
18.20 LOMBARD MEDICAL, INC. 201
18.21 MAQUET HOLDING B.V. and CO. KG (SUBSIDIARY OF GETINGE AB) 203
18.22 MEDTRONIC, INC. 206
18.23 MERIT MEDICAL SYSTEMS INC. 208
18.24 ORBUSNEICH 210
18.25 REX MEDICAL, L.P. 212
18.26 SPECTRANETICS INTERNATIONAL BV 213
18.27 ST. JUDE MEDICAL, INC. 216
18.28 TELEFLEX INC. 218
18.29 TERUMO CORPORATION 220
18.30 VASCULAR SOLUTIONS, INC. 222
18.31 VOLCANO CORPORATION 224
18.32 W. L. GORE and ASSOCIATES, INC. 226
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.

19 APPENDIX 227
19.1 INSIGHTS FROM INDUSTRY EXPERTS 227
19.2 DISCUSSION GUIDE 228
19.3 AVAILABLE CUSTOMIZATIONS 232
19.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 233
19.5 RELATED REPORTS 234


LIST OF TABLES

TABLE 1 TECHNOLOGICAL ADVANCEMENTS TO BOOST THE MARKET GROWTH FOR INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES 51
TABLE 2 AVAILABILITY OF EFFECTIVE CONVENTIONAL FIRST-LEVEL MEDICATION TO LIMIT THE MARKET GROWTH FOR INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES 52
TABLE 3 GROWTH PROSPECTS IN EMERGING COUNTRIES TO FUEL MARKET GROWTH 53
TABLE 4 IRREGULAR REIMBURSEMENT: A MAJOR CHALLENGE IN THE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET 54
TABLE 5 LIST OF U.S. FDA APPROVED PRODUCTS 58
TABLE 6 LIST OF CE-MARKED PRODUCTS 59
TABLE 7 ANGIOPLASTY MARKET SIZE, BY TYPE, 2012-2019 (NO. OF PROCEDURES) 61
TABLE 8 ANGIOPLASTY MARKET SIZE, BY REGION, 2012-2019 (NO. OF PROCEDURES) 62
TABLE 9 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY MARKET SIZE,
BY REGION, 2012-2019 (NO. OF PROCEDURES) 63
TABLE 10 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY MARKET SIZE, BY REGION,
2012-2019 (NO. OF PROCEDURES) 63
TABLE 11 ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 65
TABLE 12 ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 66
TABLE 13 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 66
TABLE 14 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 67
TABLE 15 NORTH AMERICA: OLD/NORMAL ANGIOPLASTY BALLOONS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 68
TABLE 16 CUTTING and SCORING ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 69
TABLE 17 NORTH AMERICA: CUTTING and SCORING ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 69
TABLE 18 DRUG-ELUTING ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 70
TABLE 19 NORTH AMERICA: DRUG-ELUTING ANGIOPLASTY BALLOONS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 70
TABLE 20 ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 74
TABLE 21 ANGIOPLASTY STENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 75
TABLE 22 NORTH AMERICA: ANGIOPLASTY STENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 75
TABLE 23 BARE-METAL ANGIOPLASTY STENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 76
TABLE 24 NORTH AMERICA: BARE-METAL ANGIOPLASTY STENTS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 77
TABLE 25 DRUG-ELUTING ANGIOPLASTY STENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 78
TABLE 26 NORTH AMERICA: DRUG-ELUTING ANGIOPLASTY STENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 78
TABLE 27 BIOABSORBABLE ANGIOPLASTY STENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 79
TABLE 28 NORTH AMERICA: BIOABSORBABLE ANGIOPLASTY STENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 79
TABLE 29 CATHETERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 83
TABLE 30 CATHETERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 83
TABLE 31 NORTH AMERICA: CATHETERS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 83
TABLE 32 GUIDING CATHETERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 84
TABLE 33 GUIDING CATHETERS MARKET SIZE, BY REGION, 2012-2019 (THOUSAND UNITS) 84
TABLE 34 NORTH AMERICA: GUIDING CATHETERS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 85
TABLE 35 ANGIOGRAPHY CATHETERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 86
TABLE 36 NORTH AMERICA: ANGIOGRAPHY CATHETERS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 86
TABLE 37 IVUS/OCT CATHETERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 88
TABLE 38 IVUS/OCT CATHETERS MARKET SIZE, BY REGION, 2012-2019 (THOUSAND UNITS) 88
TABLE 39 NORTH AMERICA: IVUS/OCT CATHETERS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 89
TABLE 40 EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 91
TABLE 41 EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 92
TABLE 42 EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2012-2019 (NO. OF PROCEDURES) 92
TABLE 43 EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2012-2019
(NO. OF PROCEDURES) 92
TABLE 44 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 93
TABLE 45 EVAR STENT GRAFTS MARKET SIZE FOR ABDOMINAL AORTIC ANEURYSMS,
BY REGION, 2012-2019 ($MILLION) 94
TABLE 46 EVAR STENT GRAFTS MARKET SIZE FOR ABDOMINAL AORTIC ANEURYSMS,
BY REGION, 2012-2019 (NO. OF PROCEDURES) 94
TABLE 47 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE FOR ABDOMINAL AORTIC ANEURYSMS, BY COUNTRY, 2012-2019 ($MILLION) 95
TABLE 48 EVAR STENT GRAFTS MARKET SIZE FOR THORACIC AORTIC ANEURYSMS,
BY REGION, 2012-2019 ($MILLION) 96
TABLE 49 EVAR STENT GRAFTS MARKET SIZE FOR THORACIC AORTIC ANEURYSMS,
BY REGION, 2012-2019 (NO. OF PROCEDURES) 96
TABLE 50 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE FOR THORACIC AORTIC ANEURYSMS, BY COUNTRY, 2012-2019 ($MILLION) 97
TABLE 51 IVC FILTERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 99
TABLE 52 IVC FILTERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 100
TABLE 53 IVC FILTERS MARKET SIZE, BY TYPE, 2012-2019 (NO. OF UNITS) 100
TABLE 54 IVC FILTERS MARKET SIZE, BY REGION, 2012-2019 (NO. OF UNITS) 101
TABLE 55 NORTH AMERICA: IVC FILTERS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 101
TABLE 56 IVC FILTERS MARKET SIZE FOR PERMANENT FILTERS, BY REGION,
2012-2019 ($MILLION) 102
TABLE 57 IVC FILTERS MARKET SIZE FOR PERMANENT FILTERS, BY REGION,
2012-2019 (NO. OF UNITS) 102
TABLE 58 NORTH AMERICA: IVC FILTERS MARKET SIZE FOR PERMANENT FILTERS,
BY COUNTRY, 2012-2019 ($MILLION) 103
TABLE 59 IVC FILTERS MARKET SIZE FOR RETRIEVABLE FILTERS, BY REGION,
2012-2019 ($MILLION) 103
TABLE 60 IVC FILTERS MARKET SIZE FOR RETRIEVABLE FILTERS, BY REGION,
2012-2019 (NO. OF UNITS) 104
TABLE 61 NORTH AMERICA: IVC FILTERS MARKET SIZE FOR RETRIEVABLE FILTERS,
BY COUNTRY, 2012-2019 ($MILLION) 104
TABLE 62 PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 106
TABLE 63 PLAQUE MODIFICATION DEVICES MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 107
TABLE 64 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 107
TABLE 65 PLAQUE MODIFICATION DEVICES MARKET SIZE FOR THROMBECTOMY DEVICES, BY REGION, 2012-2019 ($MILLION) 108
TABLE 66 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET SIZE FOR THROMBECTOMY DEVICES, BY COUNTRY, 2012-2019 ($MILLION) 109
TABLE 67 PLAQUE MODIFICATION DEVICES MARKET SIZE FOR ATHERECTOMY DEVICES,
BY REGION, 2012-2019 ($MILLION) 109
TABLE 68 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET SIZE FOR ATHERECTOMY DEVICES, BY COUNTRY, 2012-2019 ($MILLION) 110
TABLE 69 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 112
TABLE 70 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 113
TABLE 71 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 113
TABLE 72 EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 114
TABLE 73 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 115
TABLE 74 CHRONIC TOTAL OCCLUSION DEVICES MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 116
TABLE 75 NORTH AMERICA: CHRONIC TOTAL OCCLUSION DEVICES MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 116
TABLE 76 ACCESSORIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 118
TABLE 77 ACCESSORIES MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 119
TABLE 78 ACCESSORIES MARKET SIZE, BY TYPE, 2012-2019 (NO. OF THOUSAND UNITS) 119
TABLE 79 NORTH AMERICA: ACCESSORIES MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 120
TABLE 80 ACCESSORIES MARKET SIZE FOR VASCULAR CLOSURE DEVICES, BY REGION, 2012-2019 ($MILLION) 121
TABLE 81 ACCESSORIES MARKET SIZE FOR VASCULAR CLOSURE DEVICES, BY REGION, 2012-2019 (NO. OF THOUSAND UNITS) 121
TABLE 82 NORTH AMERICA: ACCESSORIES MARKET SIZE FOR VASCULAR CLOSURE DEVICES, BY COUNTRY, 2012-2019 ($MILLION) 122
TABLE 83 ACCESSORIES MARKET SIZE FOR INTRODUCER SHEATHS, BY REGION,
2012-2019 ($MILLION) 122
TABLE 84 ACCESSORIES MARKET SIZE FOR INTRODUCER SHEATHS, BY REGION,
2012-2019 (NO. OF THOUSAND UNITS) 123
TABLE 85 NORTH AMERICA: ACCESSORIES MARKET SIZE FOR INTRODUCER SHEATHS,
BY COUNTRY, 2012-2019 ($MILLION) 123
TABLE 86 ACCESSORIES MARKET SIZE FOR GUIDE WIRES, BY REGION,
2012-2019 ($MILLION) 124
TABLE 87 ACCESSORIES MARKET SIZE FOR GUIDE WIRES, BY REGION, 2012-2019
(NO. OF THOUSAND UNITS) 124
TABLE 88 NORTH AMERICA: ACCESSORIES MARKET SIZE FOR GUIDE WIRES,
BY COUNTRY, 2012-2019 ($MILLION) 125
TABLE 89 ACCESSORIES MARKET SIZE FOR BALLOON INFLATION DEVICES, BY REGION, 2012-2019 ($MILLION) 125
TABLE 90 ACCESSORIES MARKET SIZE FOR BALLOON INFLATION DEVICES, BY REGION, 2012-2019 (NO. OF THOUSAND UNITS) 126
TABLE 91 NORTH AMERICA: ACCESSORIES MARKET SIZE FOR BALLOON INFLATION DEVICES, BY COUNTRY, 2012-2019 ($MILLION) 126
TABLE 92 INTERVENTIONAL CARDIOLOGY and PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 129
TABLE 93 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY and PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 131
TABLE 94 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY and PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 131
TABLE 95 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 132
TABLE 96 NORTH AMERICA: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 132
TABLE 97 NORTH AMERICA: CATHETERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 132
TABLE 98 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 133
TABLE 99 NORTH AMERICA: IVC FILTERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 133
TABLE 100 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 133
TABLE 101 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 134
TABLE 102 NORTH AMERICA: ACCESSORIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 134
TABLE 103 U.S.: INTERVENTIONAL CARDIOLOGY and PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 136
TABLE 104 U.S.: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 136
TABLE 105 U.S.: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 137
TABLE 106 U.S.: CATHETERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 137
TABLE 107 U.S.: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 137
TABLE 108 U.S.: IVC FILTERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 138
TABLE 109 U.S.: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 138
TABLE 110 U.S.: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 138
TABLE 111 U.S.: ACCESSORIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 139
TABLE 112 CANADA: INTERVENTIONAL CARDIOLOGY and PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 140
TABLE 113 CANADA: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 140
TABLE 114 CANADA: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 141
TABLE 115 CANADA: CATHETERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 141
TABLE 116 CANADA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 141
TABLE 117 CANADA: IVC FILTERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 142
TABLE 118 CANADA: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 142
TABLE 119 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 142
TABLE 120 CANADA: ACCESSORIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 143
TABLE 121 EUROPE: INTERVENTIONAL CARDIOLOGY and PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 145
TABLE 122 EUROPE: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 145
TABLE 123 EUROPE: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 146
TABLE 124 EUROPE: CATHETERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 146
TABLE 125 EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 146
TABLE 126 EUROPE: IVC FILTERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 147
TABLE 127 EUROPE: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 147
TABLE 128 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 147
TABLE 129 EUROPE: ACCESSORIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 148
TABLE 130 ASIA: INTERVENTIONAL CARDIOLOGY and PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 150
TABLE 131 ASIA: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 151
TABLE 132 ASIA: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 151
TABLE 133 ASIA: CATHETERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 151
TABLE 134 ASIA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 152
TABLE 135 ASIA: IVC FILTERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 152
TABLE 136 ASIA: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 152
TABLE 137 ASIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 153
TABLE 138 ASIA: ACCESSORIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 153
TABLE 139 ROW: INTERVENTIONAL CARDIOLOGY and PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 154
TABLE 140 ROW: ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 155
TABLE 141 ROW: ANGIOPLASTY STENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 155
TABLE 142 ROW: CATHETERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 155
TABLE 143 ROW: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 156
TABLE 144 ROW: IVC FILTERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 156
TABLE 145 ROW: PLAQUE MODIFICATION DEVICES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 156
TABLE 146 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 157
TABLE 147 ROW: ACCESSORIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 157
TABLE 148 REGULATORY APPROVALS, 2012-2015 161
TABLE 149 NEW PRODUCT LAUNCHES, 2012-2015 162
TABLE 150 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015 163
TABLE 151 ACQUISITIONS, 2012-2015 164
TABLE 152 OTHER DEVELOPMENTS, 2012-2015 165


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 25
FIGURE 2 TOP-DOWN APPROACH 27
FIGURE 3 BOTTOM-UP APPROACH 27
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 28
FIGURE 5 DATA TRIANGULATION METHODOLOGY 29
FIGURE 6 MARKET SNAPSHOT (2014 VS. 2019): ANGIOPLASTY STENTS SEGMENT TO DOMINATE THE MARKET FROM 2014 TO 2019 33
FIGURE 7 ASIA TO WITNESS HIGHEST GROWTH RATE IN THE IVUS/OCT CATHETERS MARKET FROM 2014 TO 2019 34
FIGURE 8 ATHERECTOMY DEVICES TO WITNESS FASTEST GROWTH FROM 2014 TO 2019 34
FIGURE 9 NORTH AMERICA TO DOMINATE THE VASCULAR CLOSURE DEVICES MARKET, 2014-2019 35
FIGURE 10 GEOGRAPHICAL ANALYSIS OF THE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET 36
FIGURE 11 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET TO GROW AT HIGH RATE 37
FIGURE 12 DRUG-ELUTING STENTS HELD THE LARGEST MARKET SHARE AMONG ANGIOPLASTY STENTS IN 2014 38
FIGURE 13 U.S. COMMANDED ONE-THIRD OF THE MARKET SHARE IN 2014 39
FIGURE 14 ATHERECTOMY SEGMENT TO GROW AT THE HIGHEST CAGR IN THE PLAQUE MODIFICATION DEVICES MARKET 40
FIGURE 15 EMBOLIC PROTECTION DEVICES SEGMENT TO GROW AT HIGHEST RATE AMONG HEMODYNAMIC FLOW ALTERATION DEVICES 41
FIGURE 16 IVUS/OCT SEGMENT WILL CONTINUE TO LEAD THE CATHETERS MARKET IN THE FORECAST PERIOD 42
FIGURE 17 ASIA TO WITNESS HIGH GROWTH IN THE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET DURING FORECAST PERIOD 43
FIGURE 18 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
FIGURE 19 PORTER'S FIVE FORCES ANALYSIS 55
FIGURE 20 SUPPLY CHAIN ANALYSIS 57
FIGURE 21 PTCA PROCEDURES WILL DOMINATE THE MARKET IN THE FORECAST PERIOD 61
FIGURE 22 DRUG-ELUTING BALLOONS WILL DOMINATE THE ANGIOPLASTY BALLOONS MARKET IN THE FORECAST PERIOD 65
FIGURE 23 DRUG-ELUTING STENTS TO DOMINATE THE MARKET DURING THE
FORECAST PERIOD 74
FIGURE 24 IVUS/OCT MARKET TO GROW AT HIGHEST CAGR IN THE FORECAST PERIOD 82
FIGURE 25 ABDOMINAL AORTIC ANEURYSMS TO DOMINATE THE GLOBAL EVAR STENT GRAFTS MARKET DURING THE FORECAST PERIOD 91
FIGURE 26 EVAR STENT GRAFTS MARKET IN ASIA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 95
FIGURE 27 RETRIEVABLE FILTERS SEGMENT TO DOMINATE MARKET IN FORECAST PERIOD 99
FIGURE 28 ATHERECTOMY DEVICES MARKET TO GROW AT HIGHEST CAGR IN THE
FORECAST PERIOD 106
FIGURE 29 MARKET FOR EMBOLIC PROTECTION DEVICES TO GROW AT HIGHEST CAGR IN THE FORECAST PERIOD 112
FIGURE 30 GUIDE WIRES SEGMENT DOMINATES THE ACCESSORIES MARKET 118
FIGURE 31 GEOGRAPHIC SNAPSHOT (2014): EMERGING MARKETS HOLD SIGNIFICANT GROWTH OPPORTUNITIES 128
FIGURE 32 ASIA, AN ATTRACTIVE MARKET FOR INTERVENTIONAL CARDIOLOGY and PERIPHERAL VASCULAR DEVICES 129
FIGURE 33 INCREASING DEMAND FOR INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES DRIVING MARKET GROWTH 130
FIGURE 34 ATHERECTOMY DEVICES WILL DOMINATE THE PLAQUE MODIFICATION DEVICES MARKET IN THE U.S. 135
FIGURE 35 ANGIOPLASTY STENTS WILL CONTINUE TO HOLD LARGEST SHARE IN THE EUROPEAN MARKET FROM 2014 TO 2019 144
FIGURE 36 ASIAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET GROWING AT THE HIGHEST CAGR (2014-2019) 149
FIGURE 37 REGULATORY APPROVALS WAS THE MAJOR STRATEGY ADOPTED BY PLAYERS IN THE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET 158
FIGURE 38 GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2014 159
FIGURE 39 BATTLE FOR MARKET SHARE: REGULATORY APPROVALS WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS 160
FIGURE 40 PRODUCT BENCHMARKING FOR TOP 3 MARKET PLAYERS 166
FIGURE 41 ABBOTT LABORATORIES: COMPANY SNAPSHOT 167
FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT 170
FIGURE 43 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 176
FIGURE 44 BIOSENSORS INTERNATIONAL GROUP LTD: COMPANY SNAPSHOT 179
FIGURE 45 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 184
FIGURE 46 C.R. BARD: COMPANY SNAPSHOT 188
FIGURE 47 JOHNSON and JOHNSON: COMPANY SNAPSHOT 191
FIGURE 48 EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT 193
FIGURE 49 ENDOLOGIX, INC.: COMPANY SNAPSHOT 196
FIGURE 50 LOMBARD MEDICAL, INC.: COMPANY SNAPSHOT 201
FIGURE 51 GETINGE GROUP: COMPANY SNAPSHOT 203
FIGURE 52 MEDTRONIC, INC.: COMPANY SNAPSHOT 206
FIGURE 53 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 208
FIGURE 54 SPECTRANETICS INTERNATIONAL BV: COMPANY SNAPSHOT 213
FIGURE 55 ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT 216
FIGURE 56 TELEFLEX INC.: COMPANY SNAPSHOT 218
FIGURE 57 TERUMO CORPORATION: COMPANY SNAPSHOT 220
FIGURE 58 VASCULAR SOLUTIONS: COMPANY SNAPSHOT 222
FIGURE 59 VOLCANO CORPORATION: COMPANY SNAPSHOT 224

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Dialysis Catheters 2017 - MedCore

European Market Report for Dialysis Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European market for dialysis catheters comprises the acute hemodialysis, chronic hemodialysis and peritoneal dialysis catheter segments. The chronic hemodialysis catheter market is segmented ...

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

Vascular Access Devices Market: Scope and Methodology Vascular access devices are medical devices used to obtain access to the bloodstream, and are hollow and flexible tubes made of latex, silicone, and ...

Czech Republic Interventional Cardiology Market Outlook to 2022

Czech Republic Interventional Cardiology Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Czech Republic Interventional Cardiology Market Outlook to 2022 Summary GlobalData’s new report, Czech Republic Interventional Cardiology Market Outlook to 2022, provides key market data on the Czech ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.